Novo`s Amylin Injectable Cagrilintide Achieves 11.8% Weight Loss
16 Sep 2025 //
BIOSPACE
Novo Nordisk Unveils Phase 3 Data for Amylin Cagrilintide
16 Sep 2025 //
GLOBENEWSWIRE
Novo Nordisk Reports Strong Weight Loss Results For Dual-Acting Oral Drug
11 Sep 2024 //
FIERCE BIOTECH